Skip to main content
. 2014 Jun;95(6):951–959. doi: 10.1189/jlb.0713413

Figure 4. Sim pretreatment decreases RV-induced pSTAT1 in human blood monocytes in a dose-dependent manner.

Figure 4.

(A) Representative immunoblots for RV-16 (MOI=10) induced pSTAT1, total STAT1, and actin (loading control) at 2 h from human blood monocytes pretreated with veh or sim (0.1, 1, or 10 μM) for 24 h. (B) Band densitometry averages for pSTAT1 corrected with actin and normalized to RV treatment (n=5). Error bars indicate sem. ***P < 0.001 compared with RV treatment alone.